文献速递胃肠外科

腹腔镜单吻合口(迷你)胃旁路术15年经验:与其他减重手术的比较

15-year experience of laparoscopic single anastomosis (mini-)gastric bypass: comparison with other bariatric procedures.
PubMed 文献 · Surg Endosc · 2018-01-08

本研究基于1731例接受LSAGB作为初次减重手术的病态肥胖患者,对比LRYGB和LSG,评估手术结局、减重效果、合并症缓解及晚期并发症。结果显示LSAGB可带来持续减重和较高的合并症缓解率,修正手术率低于LRYGB和LSG。

要点

  • LSAGB术后1、5、10年%WL分别为32.7%、32.2%、29.1%,减重效果持久。
  • LSAGB在术后2-6年减重效果优于LRYGB和LSG。
  • LSAGB总体修正手术率为4.0%,低于LRYGB的5.1%和LSG的5.2%。

核心结论

  • LSAGB是治疗病态肥胖和代谢疾病的有效手术,能带来持续减重和较高的合并症缓解率。

研究设计与样本

  • 研究纳入2001年10月至2015年12月在敏盛综合医院接受LSAGB作为初次减重手术的1731例病态肥胖患者,前瞻性数据库结合回顾性分析,并与LRYGB和LSG组比较。
  • 患者平均年龄33.8±10.4岁,平均BMI 40.4±7.7 kg/m2,女性占70.0%,男性占30.0%。

主要发现

  • LSAGB平均手术时间124.6±38.8 min,术中出血39.5±38.7 ml,住院时间5.0±4.1天。
  • LSAGB术后30天主要并发症发生率为1.7%(30例),LRYGB为2.0%(16例),LSG为1.4%(15例)。
  • 术后1、5、10年随访率分别为89.3%、52.1%、43.6%。
  • LSAGB术后1、5、10年平均%WL分别为32.7%、32.2%、29.1%,平均BMI分别为27、26.9、27 kg/m2。
  • LSAGB在术后2-6年减重效果高于LRYGB和LSG;LSG血脂异常缓解率低于LSAGB和LRYGB。

关键数值与推荐

  • LSAGB总体修正手术率为4.0%(70/1731),LRYGB为5.1%,LSG为5.2%。

临床怎么用

  • LSAGB可作为病态肥胖患者的有效减重手术选项,具有持续减重、合并症缓解率高和修正手术率较低的特点。

局限性

  • 术后5年和10年随访率分别为52.1%和43.6%,远期数据存在失访偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic single anastomosis (mini-)gastric bypass (LSAGB) has been validated as a safe and effective treatment for morbid obesity. However, data of the long-term outcome remain lacking. METHODS: Between October 2001 and December 2015, 1731 morbidly obese patients who received LSAGB as primary bariatric procedure at the Min-Sheng General Hospital were recruited. Surgical outcome, weight loss, resolution of comorbidities, and late complications were followed, then compared with groups of laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG). All data derived from a prospective bariatric database and a retrospective analysis were conducted. RESULTS: The average patient age was 33.8 ± 10.4 years with a mean body mass index (BMI) of 40.4 ± 7.7 kg/m2. Of them, 70.0% were female while 30.0% were male. Mean operating time, intraoperative blood, and hospital stay of LSAGB were 124.6 ± 38.8 min, 39.5 ± 38.7 ml, and 5.0 ± 4.1 days, respectively. The 30-day post-operative major complication occurred in 30 (1.7%) of LSAGB patients, 16 (2.0%) of LRYGB, and 15 (1.4%) of LSG patients. The follow-up rates at 1, 5, and 10 years were 89.3, 52.1, and 43.6%, respectively. At postoperative 1, 5, and 10 years, the mean percentage of weight loss (%WL) of LSAGB patients were 32.7, 32.2, and 29.1%, and mean BMI became 27, 26.9, and 27 kg/m2, respectively. The LSAGB had a higher weight loss than LRYGB and LSG at 2-6 years after surgery. LSG had a lower remission rate in dyslipidemia comparing to LSAGB and LRYGB. The overall revision rate of LSAGB is 4.0% (70/1731) which was lower than the 5.1% in LRYGB and 5.2% in the LSG. CONCLUSION: LSAGB is an effective procedure for treating morbid obesity and metabolic disorders, which results in sustained weight loss and a high resolution of comorbidities.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Alkhalifah N, Lee WJ, Hai TC, et al. 15-year experience of laparoscopic single anastomosis (mini-)gastric bypass: comparison with other bariatric procedures. Surg Endosc. 2018. PMID: 29313123. doi:10.1007/s00464-017-6011-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。